Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

Also called NCT01425164

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01425164
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01425164. Randomized; triple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
Condition
Coronary Heart Disease
Condition
Angina
Condition
Hemodialysis
Intervention (Drug)
Ivabradine
Intervention (Drug)
Carvedilol
Lead sponsor
University of Campania Luigi Vanvitelli (class: other)
Collaborator
IRCCS San Raffaele (class: other)

Record details

Record id
cardio:ct-nct01425164
Content hash
fb7c070a2e1356e8b2a4cefdd36a14723a7e231f459ee1de56b89da2749a7528